Buy LGD-4033 (Ligandrol) Capsules – Next LVL Muscle

Product Overview

LGD-4033 Ligandrol Capsules offer premium, brandless research chemical encapsulated at ≥98% purity, designed exclusively for advanced laboratory investigations in analytical chemistry and selective receptor modulator research. This high-purity reference standard enables qualified researchers to examine molecular stereochemistry, solubility profiles, and physicochemical properties under strictly controlled in vitro conditions. The capsule format ensures accurate, dust-free handling with comprehensive batch documentation for reproducible non-clinical experimental workflows.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.​

Chemical Identity & Classification

LGD-4033 Ligandrol is identified by CAS number 1165910-22-4, providing standardized recognition across global chemical databases. Its molecular formula C14H12F6N2O corresponds to a molecular weight of 338.25 g/mol, delivering precise parameters for quantitative analysis and instrumental method development. Systematic name 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile, with synonyms VK5211 and Ligandrol, classifies it as a nonsteroidal synthetic analytical reagent and reference standard featuring two chiral centers ((2R,1’R) configuration). This positions it for in vitro binding affinity and selectivity studies conducted by trained laboratory personnel.

Chemical & Physical Characteristics

LGD-4033 within capsules presents as a white crystalline powder, protected by research-grade shells facilitating clean laboratory transfer operations. Solubility characteristics include >30 mg/mL in DMSO, moderate solubility in ethanol (~10 mg/mL), and low aqueous solubility, guiding solvent optimization for chromatographic separations. Physical properties encompass density 1.5±0.1 g/cm³, boiling point 439.9±45.0°C, flash point 219.8±28.7°C, LogP 4.04, and hygroscopic nature requiring desiccated storage, with the dual trifluoromethyl groups and pyrrolidine ring contributing to its lipophilic profile (XLogP3-AA ~4.8). These attributes support reliable HPLC method development, LC-MS characterization (m/z 339 [M+H]+), and vapor pressure assessments (0.0±1.1 mmHg at 25°C).

Purity & Analytical Verification

LGD-4033 Ligandrol Capsules maintain ≥98% purity across batches, authenticated through HPLC (>98% peak purity), LC-MS molecular confirmation, ¹H-NMR structural matching, and chiral HPLC verifying (2R,1’R) diastereomeric excess. Specifications control heavy metals (<5 ppm), residual solvents (ICH Q3C limits), and related substances, fulfilling analytical reference requirements. Lot-specific Certificates of Analysis (COAs) include quantitative purity data, chromatograms, mass spectra, and optical rotation measurements, available for laboratory quality systems. Orthogonal methods ensure material suitability for potency standardization and impurity profiling in research applications.

Quality Control & Batch Integrity

Manufacturing incorporates unique lot numbering tracing from chiral synthesis through capsule filling to final release testing. Process controls verify fill-weight uniformity (±3%), stereochemical integrity, and potency consistency, augmented by third-party stability assessments under ICH Q1A conditions (36-month projection at -20°C). Retention samples and comprehensive records—including synthetic route optimization, purification yields (typically >85%), and environmental monitoring—support multi-batch studies and documentation requirements. Statistical quality metrics achieve <1% lot-to-lot variation, ensuring reliability for serial analytical validations.

Safety, Handling & Laboratory Precautions

Authorized personnel handle LGD-4033 Ligandrol Capsules in controlled analytical environments using PPE: nitrile gloves, chemical-resistant goggles, lab coats, and fume hoods. Capsule inspection prevents powder release; spills demand inert absorbent containment and solvent decontamination per GHS07 irritant classification (H315/H319/H335). SDS protocols mandate eyewash stations, ventilation, and exposure minimization without non-laboratory applications. Waste streams follow hazardous chemical disposal regulations via incineration under trained supervision.

Packaging, Labeling & Storage

Capsules package in light-protective HDPE bottles or foil blisters with desiccants countering hygroscopic tendencies. Labels specify CAS 1165910-22-4, C14H12F6N2O, ≥98% purity, stereochemistry, batch identifiers, and hazard pictograms compliant with GHS/DOT standards. Store at -20°C under nitrogen atmosphere; aliquoting mitigates freeze-thaw effects, preserving >98% potency for 36 months.

Intended Research Use & Market Positioning

LGD-4033 Ligandrol Capsules target analytical laboratories, SARM binding studies, forensic reference calibration, and selectivity profiling requiring precise dosing. They facilitate Ki determinations (1 nM AR), tissue selectivity assessments, and stereospecific interactions in vitro—all within controlled frameworks. Positioned as “Next LVL Muscle” quality ≥98% pure generic reference, it enables cost-effective high-throughput screening without proprietary limitations. Essential for structure-activity mapping, chiral analytics, and modulator library development in sanctioned research contexts.

Ordering, Availability & Fulfillment

LGD-4033 Ligandrol Capsules maintain ready inventory across secure WooCommerce platforms with PCI-compliant payment processing. Discreet, temperature-controlled shipments deliver globally within 3-7 business days via tracked carriers. Dedicated support provides COA access, bulk configurations, and rapid response for researcher requirements.

Legal & Regulatory Disclaimer

LGD-4033 Ligandrol Capsules (CAS 1165910-22-4) distribute strictly for laboratory research purposes. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Purchasers verify and maintain compliance with all applicable jurisdictional regulations independently.